AzTrials
AzTrials

Dental PlaqueNCT02940821

Assessing the Effects of Three Oral Care Regimens

A study testing Toothbrushing, Fluoridated Dentifrice (.15% sodium monofluorophosphate) and Fluoridated Dentifrice Whitening System (.454% stannous fluoride with 2% hydrogen peroxide) in people with Dental Plaque and Gingivitis, run by Pearl Network at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Assessing the effects of three oral care regimen on plaque, gingivitis, and tooth whitening: A randomized, person-centric, comparative effectiveness clinical research study by the Practitioners Engaged in Applied Research and Learning (PEARL) Network. Read more about this study

Who is it for?
Ages 18 to 70 yearsHealthy volunteers can take part
Conditions the study is for
Dental Plaque, Gingivitis
What is being tested?
Toothbrushing, Fluoridated Dentifrice (.15% sodium monofluorophosphate) and Fluoridated Dentifrice Whitening System (.454% stannous fluoride with 2% hydrogen peroxide)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
142 participants
Where
1 siteUnited States
Study dates
30 May 2016to 27 Jul 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 70 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Subject males or females 18 to 70 years old (inclusive).
  • Availability for the 6 months duration of the clinical research study
  • Good general health
  • Subject able and willing to follow study procedures and instructions
  • Subject read, understood and signed an informed consent form
  • Subject present with at least 20 natural teeth in the functional dentition (excluding third molars), including the following natural (uncrowned) teeth for shading: #6, #7, #8, #9, #10, #11

Who cannot join

  • Potential subjects must NOT HAVE ANY of the following conditions:
  • Presence of orthodontic bands
  • Presence of partial removable dentures
  • Tumor(s) of the soft or hard tissues of the oral cavity
  • Restorations or crowns that would interfere with color measurements on the following teeth: #6, #7, #8 , #9, #10 \& #11 (upper six front teeth)
  • Advanced periodontal disease (purulent exudate, tooth mobility, and/or extensive loss of periodontal attachment or alveolar bone)
Show all 14Show fewer
  • Five or more carious lesions requiring immediate restorative treatment
  • Antibiotic use any time during the one month prior to entry into the study
  • Participation in any other clinical study or test panel within the one month prior to entry into the study
  • History of allergies to oral care/personal care consumer products or their ingredients.
  • On any prescription medicines that might interfere with the study outcome
  • An existing medical condition which prohibits eating or drinking for periods up to 4 hours
  • History of alcohol or drug abuse
  • Pregnant or lactating

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Frederick A. Curro, DMD, PhD

    Emerson, New Jersey, 07630

Other trials in United States

About this study

Official title: Assessing Three Oral Care Regimen on Plaque, Gingivitis, and Tooth Whitening

Assessing the effects of three oral care regimen on plaque, gingivitis, and tooth whitening: A randomized, person-centric, comparative effectiveness clinical research study by the Practitioners Engaged in Applied Research and Learning (PEARL) Network.

Read the detailed description

Six month, five visit study of plaque, gingivitis, and tooth whitening with three randomized intervention groups using FDA marketed and approved products and devices. One hundred fifty (150) subjects from the patient base of 10 PEARL Network associated dental offices on the East Coast of the United States will be entered into the clinical research study. This is a post-marketing comparative effectiveness research study. Having a total of 5 visits over a six month period. Adverse events and side effects for the products used are being assessed.

Being tested
Toothbrushing, Fluoridated Dentifrice (.15% sodium monofluorophosphate), Fluoridated Dentifrice Whitening System (.454% stannous fluoride with 2% hydrogen peroxide), Whitening (4.5% hydrogen peroxide), Other Fluoridated Dentifrice (.454% stannous fluoride)
Keywords
Tooth Whitening
Medical subject headings
Dental Plaque, Gingivitis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • ToothbrushingOther

    Also called Toothbrush

    Mechanical plaque removal

  • Fluoridated Dentifrice (.15% sodium monofluorophosphate)Other

    Fluoridated dentifrice application

  • Fluoridated Dentifrice Whitening System (.454% stannous fluoride with 2% hydrogen peroxide)Other

    Also called Fluoridated Dentifrice Whitening System (.454% stannous fluoride with 2% hydrogen peroxide) and toothbrushing

    Application of Tooth Whitening Agent in Dentifrice

  • Whitening (4.5% hydrogen peroxide)Other

    Application of Whitening Agent

  • Other Fluoridated Dentifrice (.454% stannous fluoride)Other

    Also called Fluoridated dentifrice (.454% stannous fluoride)

    Fluoridated dentifrice application

Study groups in NCT02940821
Study groupRoleWhat they receive
Whitening and DentifriceActive comparatorNot described
Receives: Other: Toothbrushing; Other: Whitening (4.5% hydrogen peroxide); Other: Other Fluoridated Dentifrice (.454% stannous fluoride)
Whitening DentifriceActive comparatorNot described
Receives: Other: Toothbrushing; Other: Fluoridated Dentifrice Whitening System (.454% stannous fluoride with 2% hydrogen peroxide)
DentifriceActive comparatorNot described
Receives: Other: Toothbrushing; Other: Fluoridated Dentifrice (.15% sodium monofluorophosphate)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Tooth Whitening Shade Evaluation

    Measured: 6 months

Secondary outcomes (3)
  1. Patient Questionnaire

    Measured: 6 months

  2. Plaque Index

    Measured: 6 months

  3. Gingival Index

    Measured: 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Oct 2016 (estimated)
  2. Study start30 May 2016
  3. Primary completion27 Jul 2017
  4. Study completion27 Jul 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Participant, Investigator, Outcomes assessor
Enrolment
142 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02940821
Sponsor's protocol ID
PRL1517
Status last verified
Nov 2017
First submitted
6 Oct 2016
Last updated
14 Nov 2017
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing Toothbrushing, Fluoridated Dentifrice (.15% sodium monofluorophosphate) and Fluoridated Dentifrice Whitening System (.454% stannous fluoride with 2% hydrogen peroxide) in people with Dental Plaque and Gingivitis, run by Pearl Network at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 14 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 14 Nov 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Tooth Whitening Shade Evaluation (time frame: 6 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Nov 2017; AzTrials last refreshed its copy on 7 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in